El Bairi K - Search Results

1

Repurposing anticancer drugs for the management of COVID-19.

El Bairi K, Trapani D, Petrillo A, Le Page C, Zbakh H, Daniele B, Belbaraka R, Curigliano G, Afqir S. El Bairi K, et al. Eur J Cancer. 2020 Dec;141:40-61. doi: 10.1016/j.ejca.2020.09.014. Epub 2020 Sep 22. Eur J Cancer. 2020. PMID: 33125946 Free PMC article. Review.

2

Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer.

El Bairi K, Kandhro AH, Gouri A, Mahfoud W, Louanjli N, Saadani B, Afqir S, Amrani M. El Bairi K, et al. Cell Oncol (Dordr). 2017 Apr;40(2):105-118. doi: 10.1007/s13402-016-0309-1. Epub 2016 Dec 15. Cell Oncol (Dordr). 2017. PMID: 27981507 Review.

3

Prediction of therapy response in ovarian cancer: Where are we now?

El Bairi K, Amrani M, Kandhro AH, Afqir S. El Bairi K, et al. Crit Rev Clin Lab Sci. 2017 Jun;54(4):233-266. doi: 10.1080/10408363.2017.1313190. Epub 2017 Apr 26. Crit Rev Clin Lab Sci. 2017. PMID: 28443762 Review.

4

The Human Cancer Pathology Atlas: An open-access source for more than 900,000 Kaplan-Meier plots and 5 million cancer tissue images.

El Bairi K, Amrani M, Afqir S. El Bairi K, et al. Biomed Pharmacother. 2017 Dec;96:1438-1439. doi: 10.1016/j.biopha.2017.10.063. Epub 2017 Oct 18. Biomed Pharmacother. 2017. PMID: 29055506 No abstract available.

5

Starvation tactics using natural compounds for advanced cancers: pharmacodynamics, clinical efficacy, and predictive biomarkers.

El Bairi K, Amrani M, Afqir S. El Bairi K, et al. Cancer Med. 2018 Jun;7(6):2221-2246. doi: 10.1002/cam4.1467. Epub 2018 May 6. Cancer Med. 2018. PMID: 29732738 Free PMC article. Review.

6

The arrival of predictive biomarkers for monitoring therapy response to natural compounds in cancer drug discovery.

El Bairi K, Atanasov AG, Amrani M, Afqir S. El Bairi K, et al. Biomed Pharmacother. 2019 Jan;109:2492-2498. doi: 10.1016/j.biopha.2018.11.097. Epub 2018 Dec 1. Biomed Pharmacother. 2019. PMID: 30551510 Free article. Review.

7

Can the microbiota predict response to systemic cancer therapy, surgical outcomes, and survival? The answer is in the gut.

El Bairi K, Jabi R, Trapani D, Boutallaka H, Ouled Amar Bencheikh B, Bouziane M, Amrani M, Afqir S, Maleb A. El Bairi K, et al. Expert Rev Clin Pharmacol. 2020 Apr;13(4):403-421. doi: 10.1080/17512433.2020.1758063. Epub 2020 May 24. Expert Rev Clin Pharmacol. 2020. PMID: 32308061 Review.

8

Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer?

El Bairi K, Afqir S, Amrani M. El Bairi K, et al. Curr Drug Targets. 2020;21(10):1026-1033. doi: 10.2174/1389450121666200425211732. Curr Drug Targets. 2020. PMID: 32334501 Review.

9

Does the "Devil" originate from the fallopian tubes?

El Bairi K, Al Jarroudi O, Le Page C, Afqir S. El Bairi K, et al. Semin Cancer Biol. 2021 Dec;77:56-66. doi: 10.1016/j.semcancer.2021.03.018. Epub 2021 Mar 22. Semin Cancer Biol. 2021. PMID: 33766647 Review.

10

Revisiting antibody-drug conjugates and their predictive biomarkers in platinum-resistant ovarian cancer.

El Bairi K, Al Jarroudi O, Afqir S. El Bairi K, et al. Semin Cancer Biol. 2021 Dec;77:42-55. doi: 10.1016/j.semcancer.2021.03.031. Epub 2021 Apr 1. Semin Cancer Biol. 2021. PMID: 33812984 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters